Addition of High-Dose Vitamin D 3 to Standard Treatment in Patients With Metastatic Colorectal Cancer
Kimmie Ng, Fang‐Shu Ou, Tyler Zemla, Nadine Jackson et autres
0 citationsJAMA
St. Luke's Mountain States Tumor Institute
Boise · US · facility
234Publications signalées
13574Citations signalées
12Thèmes principaux
Principaux domaines
Cancer Treatment and PharmacologyEconomic and Financial Impacts of CancerLymphoma Diagnosis and TreatmentLung Cancer Treatments and MutationsGlobal Cancer Incidence and ScreeningCancer survivorship and careLung Cancer Diagnosis and TreatmentChemotherapy-induced cardiotoxicity and mitigationPharmaceutical Practices and Patient OutcomesHER2/EGFR in Cancer ResearchAdvances in Oncology and RadiotherapyCancer Immunotherapy and Biomarkers
Évolution annuelle
Publications récentes
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Caio M.S.P. Rocha Lima, Greg Yothers, Thomas J. George, Howard S. Höchster et autres
0 citationsJournal of Clinical Oncology
Early-Stage High-Grade Fetal Lung Adenocarcinoma With KRAS Mutation: A Rare Presentation and Literature Review
Baoxiang Pei, Zhiliang Hu, Fen Pan
0 citationsInternational Journal of Surgical Pathology
Echocardiographic Characterization of Major League Soccer Players
Aakash Bavishi, Chinyen Chuo, George Chiampas, Robyn Bryde et autres
1 citationJACC Advances
ID #866 Liquid biopsy using multiple functional genomic tools reveals clinical and biological insights into replication repair deficient gliomas
Yoshiko Nakano, Robert Siddaway, Jose Rafael Dimayacyac, Lucie Stengs et autres
0 citationsNeuro-Oncology Pediatrics
Phase I/IIa dose finding study of triplet regimen of relatlimab (RELA) ipilimumab (IPI), and nivolumab (NIVO) in first-line therapy of metastatic melanoma (MM) (TRINITY).
Elizabeth M. Burton, Krysta McVay, D. Milton, Rodabe Navroze Amaria et autres
0 citationsJournal of Clinical Oncology
Antibody-Free and Highly Sensitive Detection of Site-Specific m 6 A Modification via Terminal-Mediated m 6 A PCR
Y P Guo, Zhaojie Yang, Hao Yang, Hongyang Qin et autres
0 citationsAnalytical Chemistry
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2
N. Coleman, Zihan Wei, A. John Iafrate, James A. Zwiebel et autres
1 citationClinical Cancer Research
Colorectal Cancer Metastatic dMMR Immunotherapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo (FFX/bev) in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC)— NRG-GI004/SWOG-S1610.
Caio Max Sao Pedro Rocha Lima, Greg Yothers, T. George, H HOCHSTER et autres
9 citationsJournal of Clinical Oncology
Ph I/IIa dose finding study of Triplet regimen of Relatlimab (RELA) Ipilimumab (IPI) and NIvolumab (NIVO) in first line TherapY of metastatic melanoma (MM) (TRINITY)
E. Burton, K. McVay, D.R. Milton, R.N. Amaria et autres
0 citationsEJC Skin Cancer
BLUEBONNET: Phase II Study of Nivolumab in combination with Relatlimab in Patients with Active Melanoma Brain Metastases
E. Burton, S. Phillips, I.C. Glitza, D.R. Milton et autres
0 citationsEJC Skin Cancer
Developing a Symptom Toolkit for Adult Lymphoma Patients Receiving Chemotherapy in Malawi
Alyssa Tilly, April Evans, Maria Chikasema, Jane S. Chen et autres
0 citationsPalliative Medicine Reports
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.